Identification of novel signal of Raynaud’s phenomenon with Calcitonin Gene-Related Peptide(CGRP) antagonists using data mining algorithms and network pharmacological approaches

Association of antiviral drugs and their possible mechanisms with DRESS syndrome using data mining algorithms

(2023) Akash Sharma et al.   JOURNAL OF MEDICAL VIROLOGY

Atogepant: an emerging treatment for migraine

(2022) Cecilia Rustichelli et al.   EXPERT OPINION ON PHARMACOTHERAPY

Alopecia signals associated with calcitonin gene‐related peptide inhibitors in the treatment or prophylaxis of migraine: A pharmacovigilance study

(2022) Richard H. Woods   PHARMACOTHERAPY

Gepants for Acute and Preventive Migraine Treatment: A Narrative Review

(2022) Jamir Pitton Rissardo et al.   Brain Sciences

Evaluation of the Safety of Calcitonin Gene-Related Peptide Antagonists for Migraine Treatment Among Adults With Raynaud Phenomenon

(2021) Ilana D. Breen et al.   JAMA Network Open

Age-dependent effects on infectivity and susceptibility to SARS-CoV-2 infection: results from nationwide contact tracing data in Greece

(2021) Angeliki Bistaraki et al.   Infectious Diseases

Contribution of Causality Assessment for an Automated Detection of Safety Signals: An Example Using the French Pharmacovigilance Database

(2020) Thomas Berbain et al.   DRUG SAFETY

Ubrogepant: First Approval

(2020) Lesley J. Scott   DRUGS

Blocking the CGRP Pathway for Acute and Preventive Treatment of Migraine: The Evolution of Success

(2020) Gene M. Dubowchik et al.   JOURNAL OF MEDICINAL CHEMISTRY

Involvement of Neural Transient Receptor Potential Channels in Peripheral Inflammation

(2020) Harold A. Silverman et al.   Frontiers in Immunology

CGRP Antagonists for the Treatment of Chronic Migraines: a Comprehensive Review

(2019) Ivan Urits et al.   Current Pain and Headache Reports

A new era for migraine: Pharmacokinetic and pharmacodynamic insights into monoclonal antibodies with a focus on galcanezumab, an anti-CGRP antibody

(2019) William Kielbasa et al.   CEPHALALGIA

Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial

(2019) David W Dodick et al.   CEPHALALGIA

Raynaud's Phenomenon Associated With Calcitonin Gene‐Related Peptide Monoclonal Antibody Antagonists

(2019) Randolph W. Evans   HEADACHE

Mammalian cold TRP channels: impact on thermoregulation and energy homeostasis

(2018) Rosa Señarís et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention

(2018) Vladimir Skljarevski et al.   JAMA Neurology

CGRP and its receptors

(2017) Debbie L. Hay et al.   HEADACHE

A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer

(2016) Francesca Vitali et al.   PLoS One

Automatic signal extraction, prioritizing and filtering approaches in detecting post-marketing cardiovascular events associated with targeted cancer drugs from the FDA Adverse Event Reporting System (FAERS)

(2013) Rong Xu et al.   JOURNAL OF BIOMEDICAL INFORMATICS

Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions

(2012) Rave Harpaz et al.   JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION

A Hypothesis for the Cause of Complex Regional Pain Syndrome-Type I (Reflex Sympathetic Dystrophy): Pain Due to Deep-Tissue Microvascular Pathology

(2010) Terence J. Coderre et al.   PAIN MEDICINE